With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...
With a new approach to creating thymus-targeted medicines for autoimmune diseases, Zag Bio has emerged from stealth with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback